Stockreport

Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe [Yahoo! Finance]

Xenon Pharmaceuticals Inc. - Common Shares  (XENE) 
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com
PDF At present, the company has no marketed drug in its portfolio. Xenon's pipeline comprises its lead product candidate, azetukalner, a differentiated Kv7 potassium chann [Read more]